MStranslate logo
Log In
Lost your password?
Lost Password
Back to login
Search
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Breaking
  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast - Episode Library
  • Patient Community Day at ECTRIMS 2025
  • Multiple Sclerosis in 2025 – Key Developments to Date
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us

Tagged Research summaries

gene mutation

New Studies Question Gene Mutation Link to MS

MStranslate
September 12, 2016
Genetics, Research
The results of an MS genetic study published in Neuron earlier this year are now being called into question. You may remember that MStranslate did a...
misdiagnosis

The Misdiagnosis of Multiple Sclerosis: A Study

MStranslate
September 1, 2016
Research
A study has provided evidence to something that has been discussed anecdotally for quite some time - a diagnosis of multiple sclerosis (MS) is...
MOMENTUM

MOMENTUM Phase II Trial Results

MStranslate
August 22, 2016
Clinical Trials, Fingolimod, Research
The background Fingolimod was approved in 2010 and became the first oral drug for the treatment of relapsing-remitting MS (RRMS).  It has proven to...
Exercise

EAE Study Shows Multiple Benefits of Exercise

MStranslate
August 1, 2016
Exercise, Lifestyle, Research
The background It is known that problems with the blood-brain barrier (BBB) and the immune system contribute to the damage seen in multiple...
gut bacteria

Gut Bacteria in People Living with RRMS

MStranslate
June 29, 2016
Diet, Lifestyle, Research
1 Comment
The background Whilst it is generally accepted that multiple sclerosis (MS) has a combination of genetic and environmental factors that contribute...
progressive multiple sclerosis

Progressive Multiple Sclerosis Linked to Gene Variation

MStranslate
June 7, 2016
Basic Sciences, Genetics, Research
Research summary: Nuclear Receptor NR1H3 in Familial Multiple Sclerosis The background Whilst the cause of multiple sclerosis remains elusive,...
Biotin

High Dose Biotin Therapy in Multiple Sclerosis

MStranslate
May 26, 2016
Biotin, Research, Treatments
3 Comments
At the start of May, we posted an update on clinical trials that were evaluating high dose biotin as a treatment for multiple sclerosis. Undertaken...
diet

Diet & Gut Bacteria Linked to Neuroinflammation

MStranslate
May 10, 2016
Diet, Lifestyle, Research
3 Comments
Research summary:  Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation...
biotin

Update on Biotin Multiple Sclerosis Clinical Trials

MStranslate
May 4, 2016
Research, Treatments
5 Comments
At the recent American Academy of Neurology (AAN) conference, MedDay provided an update on their trials into the use of their biotin compound...
Antihistamine

Antihistamine may stimulate myelin repair

MStranslate
April 13, 2016
Clinical Trials, Remyelination, Research, Treatments
1 Comment
A small, Phase II clinical trial has shown that a common over the counter antihistamine, called clemastine fumarate, has the ability to partially...
  1. 7
  2. 8
  3. 9
  4. 10
  5. 11
  6. 12
  7. 13

Recent Posts

  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Patient Community Day at ECTRIMS 2025

Recent Comments

  • FDA Decision On Tolebrutinib - MStranslate on Multiple Sclerosis in 2025 – Key Developments to Date
  • Treatment With Gut Bacteria Shows Benefits In New Study on Gut Bacteria in People Living with RRMS
  • Community Q&A: COVID-19 Vaccines & Multiple Sclerosis on Community Q&A: The Blood-Brain Barrier
  • Community Q&A: Why Don't We Have A Multiple Sclerosis Cure? on Community Q&A: COVID-19 Vaccines & MS
  • Tim Little on FAKE NEWS ALERT: COVID Vaccines & MS

Calendar

March 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
« Jan    

Archives

Categories

Posts

  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Patient Community Day at ECTRIMS 2025

Google+

Get social

Copyright 2014-2018 MStranslate. All Rights Reserved. Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.